112 related articles for article (PubMed ID: 21378601)
1. No association between CALHM1 polymorphism and Alzheimer's disease risk in a Hungarian population.
Fehér A; Juhász A; Rimanóczy A; Pákáski M; Kálmán J; Janka Z
Psychiatr Genet; 2011 Oct; 21(5):249-52. PubMed ID: 21378601
[TBL] [Abstract][Full Text] [Related]
2. Genetic association between CALHM1, 2, and 3 polymorphisms and Alzheimer's disease in a Japanese population.
Shibata N; Kuerban B; Komatsu M; Ohnuma T; Baba H; Arai H
J Alzheimers Dis; 2010; 20(2):417-21. PubMed ID: 20164573
[TBL] [Abstract][Full Text] [Related]
3. No association between CALHM1 and risk for Alzheimer dementia in a Belgian population.
Sleegers K; Brouwers N; Bettens K; Engelborghs S; van Miegroet H; De Deyn PP; Van Broeckhoven C
Hum Mutat; 2009 Apr; 30(4):E570-4. PubMed ID: 19191332
[TBL] [Abstract][Full Text] [Related]
4. Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer's disease.
Nacmias B; Tedde A; Bagnoli S; Lucenteforte E; Cellini E; Piaceri I; Guarnieri BM; Bessi V; Bracco L; Sorbi S
J Alzheimers Dis; 2010; 20(1):37-41. PubMed ID: 20164602
[TBL] [Abstract][Full Text] [Related]
5. CALHM1 variant is not associated with Alzheimer's disease among Asians.
Tan EK; Ho P; Cheng SY; Yih Y; Li HH; Fook-Chong S; Lee WL; Zhao Y
Neurobiol Aging; 2011 Mar; 32(3):546.e11-2. PubMed ID: 19545933
[TBL] [Abstract][Full Text] [Related]
6. CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model.
Boada M; Antúnez C; López-Arrieta J; Galán JJ; Morón FJ; Hernández I; Marín J; Martínez-Lage P; Alegret M; Carrasco JM; Moreno C; Real LM; González-Pérez A; Tárraga L; Ruiz A
J Alzheimers Dis; 2010; 20(1):247-51. PubMed ID: 20164592
[TBL] [Abstract][Full Text] [Related]
7. A polymorphism in CALHM1 is associated with temporal lobe epilepsy.
Lv RJ; He JS; Fu YH; Shao XQ; Wu LW; Lu Q; Jin LR; Liu H
Epilepsy Behav; 2011 Apr; 20(4):681-5. PubMed ID: 21439911
[TBL] [Abstract][Full Text] [Related]
8. Genetic association of complement receptor 1 polymorphism rs3818361 in Alzheimer's disease.
Antúnez C; Boada M; López-Arrieta J; Moreno-Rey C; Hernández I; Marín J; Gayán J; ; González-Pérez A; Real LM; Alegret M; Tárraga L; Ramírez-Lorca R; Ruiz A
Alzheimers Dement; 2011 Jul; 7(4):e124-9. PubMed ID: 21784344
[TBL] [Abstract][Full Text] [Related]
9. Calcium homeostasis modulator 1 gene P86L polymorphism and the risk for alzheimer's disease: A meta-analysis.
Mun MJ; Kim JH; Choi JY; Jang WC
Neurosci Lett; 2016 Apr; 619():8-14. PubMed ID: 26944452
[TBL] [Abstract][Full Text] [Related]
10. Genetic association of CALHM1 rs2986017 polymorphism with risk of Alzheimer's disease: a meta-analysis.
Lu Y; Liu W; Tan K; Peng J; Zhu Y; Wang X
Neurol Sci; 2016 Apr; 37(4):525-32. PubMed ID: 26700797
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease: The latest suspect.
Tanzi RE; Bertram L
Nature; 2008 Aug; 454(7205):706-8. PubMed ID: 18685694
[No Abstract] [Full Text] [Related]
12. No association between CALHM1 variation and risk of Alzheimer disease.
Minster RL; Demirci FY; DeKosky ST; Kamboh MI
Hum Mutat; 2009 Apr; 30(4):E566-9. PubMed ID: 19191331
[TBL] [Abstract][Full Text] [Related]
13. CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease.
Koppel J; Campagne F; Vingtdeux V; Dreses-Werringloer U; Ewers M; Rujescu D; Hampel H; Gordon ML; Christen E; Chapuis J; Greenwald BS; Davies P; Marambaud P
Mol Med; 2011; 17(9-10):974-9. PubMed ID: 21629967
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study.
Quan W; Yasuda M; Hashimoto M; Yamamoto Y; Ishii K; Kazui H; Mori E; Kakigi T; Maeda K
J Neurol Sci; 2006 Jan; 240(1-2):71-5. PubMed ID: 16233903
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent association of KIBRA genetic variation and Alzheimer's disease risk.
Rodríguez-Rodríguez E; Infante J; Llorca J; Mateo I; Sánchez-Quintana C; García-Gorostiaga I; Sánchez-Juan P; Berciano J; Combarros O
Neurobiol Aging; 2009 Feb; 30(2):322-4. PubMed ID: 17707552
[TBL] [Abstract][Full Text] [Related]
16. Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.
Zhang Q; Yu JT; Zhu QX; Zhang W; Wu ZC; Miao D; Tan L
Brain Res; 2010 Aug; 1348():216-21. PubMed ID: 20558149
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
[TBL] [Abstract][Full Text] [Related]
18. Association of IL10 promoter polymorphism in Italian Alzheimer's disease.
Bagnoli S; Cellini E; Tedde A; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
Neurosci Lett; 2007 May; 418(3):262-5. PubMed ID: 17420099
[TBL] [Abstract][Full Text] [Related]
19. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
[TBL] [Abstract][Full Text] [Related]
20. Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease.
Yao L; Li K; Zhang L; Yao S; Piao Z; Song L
Brain Res; 2009 Sep; 1291():133-9. PubMed ID: 19631630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
